Back to resultsA Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)
Primary Purpose
Rheumatoid Arthritis
Status
Recruiting
Phase
Phase 2
Locations
International
Study Type
Interventional
Intervention
Rosnilimab
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Rheumatoid Arthritis focused on measuring PD-1 Agonist, ANB030, RENOIR, Rosnilimab
Eligibility Criteria
Key Inclusion Criteria: Aged 18 years or older A diagnosis of Rheumatoid Arthritis based on ACR/EULAR 2010 classification criteria, for at least 3 months before participating in the trial Must be receiving treatment with at least 1, but not more than 2 csDMARDs for at least 3 months and be on stable dosages for at least 8 weeks prior to joining and throughout the trial Have had an inadequate response to, or loss of response or intolerance to at least 1 conventional synthetic DMARD (csDMARD), biologic DMARD (bDMARD), or targeted synthetic DMARD (tsDMARD) treatment Key Exclusion Criteria: History of an inflammatory joint disease other than Rheumatoid Arthritis Prior exposure to a PD-1 or PD-L1 agonist, antagonist, or modulator History of cancer within the last 5 years (except for some skin cancers) Any known or suspected condition that would compromise immune status Pregnant or breastfeeding women
Sites / Locations
- Anaptys Bio Investigative Site 10-132
- Anaptys Bio Investigative Site 10-130
- Anaptys Bio Investigative Site 10-129
- Anaptys Bio Investigative Site 10-131
- Anaptys Bio Investigative Site 10-105
- Anaptys Bio Investigative Site 10-126
- Anaptys Bio Investigative Site 10-119
- Anaptys Bio Investigative Site 10-113
- Anaptys Bio Investigative Site 10-127
- Anaptys Bio Investigative Site 10-133
- AnaptysBio Investigative Site 10-112Recruiting
- AnaptysBio Investigative Site 10-103
- Anaptys Bio Investigative Site 10-118
- Anaptys Bio Investigative Site 10-115
- Anaptys Bio Investigative Site 10-125
- AnaptysBio Investigative Site 10-122
- AnaptysBio Investigative Site 10-102
- AnaptysBio Investigative Site 10-124
- Anaptys Bio Investigative Site 10-114
- Anaptys Bio Investigative Site 10-134
- Anaptys Bio Investigative Site 10-116
- AnaptysBio Investigative Site 10-101Recruiting
- Anaptys Bio Investigative Site 10-120
- Anaptys Bio Investigative Site 10-107Recruiting
- Anaptys Bio Investigative Site 10-123
- AnaptysBio Investigative Site 10-108
- Anaptys Bio Investigative Site 10-110
- Anaptys Bio Investigative Site 10-106
- Anaptys Bio Investigative Site 10-121
- Anaptys Bio Investigative Site 10-117
- AnaptysBio Investigative Site 47-101
- AnaptysBio Investigative Site 47-104
- AnaptysBio Investigative Site 47-102
- AnaptysBio Investigative Site 47-105
- AnaptysBio Investigative Site 47-103
- AnaptysBio Investigative Site 47-105
- Anaptys Bio Investigative Site 13-102
- Anaptys Bio Investigative Site 13-104
- Anaptys Bio Investigative Site 13-103
- Anaptys Bio Investigative Site 13-101
- Anaptys Bio Investigative Site 13- 105
- Anaptys Bio Investigative Site 11-102
- Anaptys Bio Investigative Site 11-104
- Anaptys Bio Investigative Site 11-101
- Anaptys Bio Investigative Site 11-103
- Anaptys Bio Investigative Site 71-103
- Anaptys Bio Investigative Site 71-102
- AnaptysBio Investigative Site 71-101
- AnaptysBio Investigative Site 59-101Recruiting
- AnaptysBio Investigative Site 59-105
- AnaptysBio Investigative Site 59-104Recruiting
- AnaptysBio Investigative Site 59-106Recruiting
- AnaptysBio Investigative Site 59-102Recruiting
- AnaptysBio Investigative Site 59-103Recruiting
- Anaptys Bio Investigative Site 10-122
- AnaptysBio Investigative Site 28-102
- AnaptysBio Investigative Site 28-103
- AnaptysBio Investigative Site 28-101
- Anaptys Bio Investigative Site 28-106
- AnaptysBio Investigative Site 28-104
- AnaptysBio Investigative Site 20-101
- AnaptysBio Investigative Site 20-103
- AnaptysBio Investigative Site 20-102
- AnaptysBio Investigative Site 51-102
- AnaptysBio Investigational Site 51-104
- AnaptysBio Investigational Site 51-107
- AnaptysBio Investigative Site 51-106
- AnaptysBio Investigational Site 51-105
- AnaptysBio Investigative Site 73-101
- AnaptysBio Investigative Site 72-103
- AnaptysBio Investigative Site 72-104
- AnaptysBio Investigative Site 72-102
- AnaptysBio Investigative Site 30-104
- AnaptysBio Investigative Site 30-103
- AnaptysBio Investigative Site 30-107
- AnaptysBio Investigative Site 30-106
- AnaptysBio Investigative Site 30-112
- AnaptysBio Investigative Site 30-105
- AnaptysBio Investigative Site 30-101
- AnaptysBio Investigative Site 30-102
- AnaptysBio Investigative Site 30-111
- AnaptysBio Investigative Site 30-109
- AnaptysBio Investigative Site 30-108
- AnaptysBio Investigative Site 67-101
- AnaptysBio Investigative Site 24-101
- AnaptysBio Investigative Site 24-102
- AnaptysBio Investigative Site 24-105
- AnaptysBio Investigative Site 24-104
- AnaptysBio Investigative Site 24-103
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Placebo Comparator
Arm Label
Rosnilimab SC Dose 1
Rosnilimab SC Dose 2
Rosnilimab SC Dose 3
Placebo
Arm Description
This arm will receive treatment SC
This arm will receive treatment SC
This arm will receive treatment SC
This arm will receive Placebo
Outcomes
Primary Outcome Measures
Mean change from Baseline in 28-Joint Disease Activity Score based on CRP (DAS28-CRP) at Week 12
The DAS28-CRP is a validated composite assessment that assesses RA disease activity based on tender and swollen joint counts of 28 joints
Secondary Outcome Measures
American College of Rheumatology 20% Improvement Criteria (ACR20) response rate at Week 12
American College of Rheumatology 50% and 70% Improvement Criteria (ACR50 and ACR70) response rates at Week 12
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT06041269
Brief Title
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)
Official Title
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 31, 2023 (Actual)
Primary Completion Date
March 8, 2025 (Anticipated)
Study Completion Date
October 8, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AnaptysBio, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)
Detailed Description
This study is a Phase 2 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis
Keywords
PD-1 Agonist, ANB030, RENOIR, Rosnilimab
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
420 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Rosnilimab SC Dose 1
Arm Type
Experimental
Arm Description
This arm will receive treatment SC
Arm Title
Rosnilimab SC Dose 2
Arm Type
Experimental
Arm Description
This arm will receive treatment SC
Arm Title
Rosnilimab SC Dose 3
Arm Type
Experimental
Arm Description
This arm will receive treatment SC
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
This arm will receive Placebo
Intervention Type
Drug
Intervention Name(s)
Rosnilimab
Other Intervention Name(s)
ANB030
Intervention Description
PD-1 agonist antibody
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Mean change from Baseline in 28-Joint Disease Activity Score based on CRP (DAS28-CRP) at Week 12
Description
The DAS28-CRP is a validated composite assessment that assesses RA disease activity based on tender and swollen joint counts of 28 joints
Time Frame
Baseline to Week 12
Secondary Outcome Measure Information:
Title
American College of Rheumatology 20% Improvement Criteria (ACR20) response rate at Week 12
Time Frame
Baseline to Week 12
Title
American College of Rheumatology 50% and 70% Improvement Criteria (ACR50 and ACR70) response rates at Week 12
Time Frame
Baseline to Week 12
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Key Inclusion Criteria:
Aged 18 years or older
A diagnosis of Rheumatoid Arthritis based on ACR/EULAR 2010 classification criteria, for at least 3 months before participating in the trial
Must be receiving treatment with at least 1, but not more than 2 csDMARDs for at least 3 months and be on stable dosages for at least 8 weeks prior to joining and throughout the trial
Have had an inadequate response to, or loss of response or intolerance to at least 1 conventional synthetic DMARD (csDMARD), biologic DMARD (bDMARD), or targeted synthetic DMARD (tsDMARD) treatment
Key Exclusion Criteria:
History of an inflammatory joint disease other than Rheumatoid Arthritis
Prior exposure to a PD-1 or PD-L1 agonist, antagonist, or modulator
History of cancer within the last 5 years (except for some skin cancers)
Any known or suspected condition that would compromise immune status
Pregnant or breastfeeding women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
AnaptysBio Clinical Trial Inbox
Phone
858-362-2093
Email
Clinicaltrialinfo@anaptysbio.com
Facility Information:
Facility Name
Anaptys Bio Investigative Site 10-132
City
Flagstaff
State/Province
Arizona
ZIP/Postal Code
86001
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-130
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85306
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-129
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85037
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-131
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85704
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-105
City
Covina
State/Province
California
ZIP/Postal Code
91722
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-126
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-119
City
Rancho Mirage
State/Province
California
ZIP/Postal Code
92270
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-113
City
San Diego
State/Province
California
ZIP/Postal Code
92108
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-127
City
San Francisco
State/Province
California
ZIP/Postal Code
94123
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-133
City
Upland
State/Province
California
ZIP/Postal Code
91786
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-112
City
Whittier
State/Province
California
ZIP/Postal Code
90602
Country
United States
Individual Site Status
Recruiting
Facility Name
AnaptysBio Investigative Site 10-103
City
Aventura
State/Province
Florida
ZIP/Postal Code
33180
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-118
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33436
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-115
City
Brandon
State/Province
Florida
ZIP/Postal Code
33511
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-125
City
Daytona Beach
State/Province
Florida
ZIP/Postal Code
32117
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-122
City
Homestead
State/Province
Florida
ZIP/Postal Code
33032
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-102
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-124
City
Plantation
State/Province
Florida
ZIP/Postal Code
33324
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-114
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60640
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-134
City
Grand Blanc
State/Province
Michigan
ZIP/Postal Code
48439
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-116
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87102
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-101
City
Jackson
State/Province
Tennessee
ZIP/Postal Code
38305
Country
United States
Individual Site Status
Recruiting
Facility Name
Anaptys Bio Investigative Site 10-120
City
Allen
State/Province
Texas
ZIP/Postal Code
75013
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-107
City
Colleyville
State/Province
Texas
ZIP/Postal Code
76034
Country
United States
Individual Site Status
Recruiting
Facility Name
Anaptys Bio Investigative Site 10-123
City
Katy
State/Province
Texas
ZIP/Postal Code
77450
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 10-108
City
Mesquite
State/Province
Texas
ZIP/Postal Code
75150
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-110
City
Plano
State/Province
Texas
ZIP/Postal Code
75024
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-106
City
The Woodlands
State/Province
Texas
ZIP/Postal Code
77382
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-121
City
Tomball
State/Province
Texas
ZIP/Postal Code
77375
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 10-117
City
Beckley
State/Province
West Virginia
ZIP/Postal Code
25801
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-101
City
Mar del Plata
State/Province
Beunos Aires
ZIP/Postal Code
7600
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-104
City
Zárate
State/Province
Beunos Aires
ZIP/Postal Code
2800
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-102
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
2000
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-105
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
2000
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-103
City
San Miguel De Tucumán
State/Province
Tucuman
ZIP/Postal Code
4000
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 47-105
City
Cordoba
ZIP/Postal Code
5016
Country
Argentina
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 13-102
City
Anderlecht
State/Province
Bruxelles
ZIP/Postal Code
1070
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 13-104
City
Leuven
State/Province
Vlaams-Braba
ZIP/Postal Code
3000
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 13-103
City
Antwerp
ZIP/Postal Code
2170
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 13-101
City
Bruxelles
ZIP/Postal Code
1200
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 13- 105
City
Liège
ZIP/Postal Code
4000
Country
Belgium
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 11-102
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N1Y2
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 11-104
City
Niagara Falls
State/Province
Ontario
ZIP/Postal Code
L2E6A6
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 11-101
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8X1T3
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 11-103
City
Trois-Rivières
State/Province
Quebec
ZIP/Postal Code
G8Z1Y2
Country
Canada
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 71-103
City
Tartu
State/Province
Tartumaa
ZIP/Postal Code
50106
Country
Estonia
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 71-102
City
Tallinn
ZIP/Postal Code
10117
Country
Estonia
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 71-101
City
Tallinn
ZIP/Postal Code
13419
Country
Estonia
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 59-101
City
Tbilisi
ZIP/Postal Code
0112
Country
Georgia
Individual Site Status
Recruiting
Facility Name
AnaptysBio Investigative Site 59-105
City
Tbilisi
ZIP/Postal Code
0131
Country
Georgia
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 59-104
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Individual Site Status
Recruiting
Facility Name
AnaptysBio Investigative Site 59-106
City
Tbilisi
ZIP/Postal Code
0159
Country
Georgia
Individual Site Status
Recruiting
Facility Name
AnaptysBio Investigative Site 59-102
City
Tbilisi
ZIP/Postal Code
0160
Country
Georgia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Site 59-101
Facility Name
AnaptysBio Investigative Site 59-103
City
Tbilisi
ZIP/Postal Code
0172
Country
Georgia
Individual Site Status
Recruiting
Facility Name
Anaptys Bio Investigative Site 10-122
City
Hamburg
ZIP/Postal Code
20095
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 28-102
City
Debrecen
State/Province
Hajdu-Bihar
ZIP/Postal Code
4032
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 28-103
City
Debrecen
State/Province
Hajdu-Bihar
ZIP/Postal Code
4032
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 28-101
City
Budapest
State/Province
Pest
ZIP/Postal Code
1023
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Anaptys Bio Investigative Site 28-106
City
Budapest
ZIP/Postal Code
1036
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 28-104
City
Budapest
ZIP/Postal Code
1036
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 20-101
City
Pavia
State/Province
PV
ZIP/Postal Code
27100
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 20-103
City
Firenze
ZIP/Postal Code
50141
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 20-102
City
Roma
ZIP/Postal Code
168
Country
Italy
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 51-102
City
San Miguel
State/Province
Ciudad De Mexico
ZIP/Postal Code
11850
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigational Site 51-104
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44160
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigational Site 51-107
City
Mexico City
ZIP/Postal Code
1120
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 51-106
City
Mexico City
ZIP/Postal Code
11650
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigational Site 51-105
City
Oaxaca
ZIP/Postal Code
68000
Country
Mexico
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 73-101
City
Chisinau
State/Province
Kishinev
ZIP/Postal Code
29
Country
Moldova, Republic of
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 72-103
City
Cayma
State/Province
Arequipa
ZIP/Postal Code
4001
Country
Peru
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 72-104
City
Bella Vista
State/Province
Callao
ZIP/Postal Code
Callao 2
Country
Peru
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 72-102
City
San Isidro
State/Province
Lima
ZIP/Postal Code
Lima 27
Country
Peru
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-104
City
Toruń
State/Province
Kuj-pom
ZIP/Postal Code
87-100
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-103
City
Nowa Sól
State/Province
Lubuskie
ZIP/Postal Code
67-100
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-107
City
Warsaw
State/Province
Mazowieckie
ZIP/Postal Code
02-118
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-106
City
Opole
State/Province
Opolskie
ZIP/Postal Code
45-819
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-112
City
Poznań
State/Province
Wielkopolskie
ZIP/Postal Code
60693
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-105
City
Poznań
State/Province
Wielkopolskie
ZIP/Postal Code
61-113
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-101
City
Poznań
State/Province
Wielkopolskie
ZIP/Postal Code
61-293
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-102
City
Bytom
State/Province
Woj.Slaskie
ZIP/Postal Code
41-902
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-111
City
Białystok
ZIP/Postal Code
15-707
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-109
City
Bydgoszcz
ZIP/Postal Code
85-065
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 30-108
City
Warsaw
ZIP/Postal Code
00-874
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 67-101
City
Košice
ZIP/Postal Code
4011
Country
Slovakia
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 24-101
City
Bilbao
State/Province
Bizkaia
ZIP/Postal Code
48013
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 24-102
City
Santiago de Compostela
State/Province
Coruna
ZIP/Postal Code
15895
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 24-105
City
Córdoba
ZIP/Postal Code
14004
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 24-104
City
Santiago De Compostela
ZIP/Postal Code
15702
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
AnaptysBio Investigative Site 24-103
City
Santiago De Compostela
ZIP/Postal Code
15706
Country
Spain
Individual Site Status
Not yet recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)
We'll reach out to this number within 24 hrs